Track the 유한양행 share price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 유한양행 has logged 109 insider filings. Market capitalisation: €5,495.2bn. The latest transaction was filed on 2 July 2026 (Purchase). Among the most active insiders: 김열홍. Every trade is openly available.
108
Insider Decl.
n/a
Thresholds
€195m
95 ops.
Buy Volume
n/a
7 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 유한양행 Buy (bullish), based on 18 analysts. Average price target: ₩127,556.
41Σ signal
Buys €195mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 15,942 of 28,169 companies
48.3
score / 100
Value
37
Quality
60
FCF yld-0.6%
Earn yld3.2%
EV/EBITDA20.7x
ROE8.9%
Gross mgn33%
Net mgn8.9%
Debt/EBITDA1.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
280 shares@ ₩94,183.000.0000% mcap62.6% of flowShareKRXDART:20260413001051
25 of 109 declarations
About 유한양행
Yuhan Corporation is a South Korean pharmaceutical company engaged in the research, development, and manufacturing of drugs. It is listed on the Korea Exchange, XKRX.